Search Results

Containing any of the words

Only of the type

Single arm Phase I/II study of the safety, tolerability and efficacy of the investigational anti PD-L1 monoclonal antibody Durvalumab in combination with Paclitaxel in patients with metastatic triple negative PD-L1 positive breast cancer Drug Clinical Trial

(WU2252) NCMDR Weakly Update Medical Report

(WU2240) NCMDR Weakly Update Medical Report

(WU2241) NCMDR Weakly Update Medical Report

Escalating Dose and Randomized, Controlled Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy Drug Clinical Trial

(WU2247) NCMDR Weakly Update Medical Report

(WU2250) NCMDR Weakly Update Medical Report

(WU2251) NCMDR Weakly Update Medical Report

(WU2249) NCMDR Weakly Update Medical Report

(WU2248) NCMDR Weakly Update Medical Report